Literature DB >> 8852269

Mechanism of inhibition of protein synthesis by macrolide and lincosamide antibiotics.

J R Menninger1.   

Abstract

During protein synthesis on the ribosome, the growing peptide is linked covalently to a transfer RNA. With a certain probability this peptidyl-tRNA dissociates from the ribosome, whereupon it becomes susceptible to hydrolysis catalyzed by peptidyl-tRNA hydrolase. When placed at nonpermissive temperatures, mutant (pthts) Escherichia coli that are temperature-sensitive for the hydrolase will accumulate peptidyl-tRNA, suffer inhibition of protein synthesis, and eventually die. Treating cells with chloramphenicol before raising the temperature prevents cell death but erythromycin, other macrolides, and lincosamide antibiotics all enhance cell death. Accumulation of peptidyl-tRNA by pthts cells at high temperatures is blocked by chloramphenicol but enhanced by macrolides and lincosamides. The data are most consistent with macrolide and lincosamide antibiotics having as their primary mechanism of inhibition the stimulation of peptidyl-tRNA dissociation from the ribosome. Rather than blocking peptide bond formation or peptidyl-tRNA translocation from the A- to the P-site of the ribosome, these antibiotics allow the synthesis of small peptides which dissociate as peptidyl-tRNAs before being completed. Low doses of erythromycin and lincomycin stimulate preferentially the dissociation of peptidyl-tRNAs that are erroneous. Errors in proteins can be assessed by the time necessary to inactivate beta-galactosidase at > 55 degrees C. Whether erroneous peptidyl-tRNAs are induced by treating E. coli with streptomycin or ethanol, or by starving for an amino acid, the shortened time to inactivate beta-galactosidase is counteracted if the cells are simultaneously treated with erythromycin or lincomycin. In contrast, errors in beta-galactosidase caused by synthesis in the presence of canavanine, an arginine analogue, cannot be counteracted by the simultaneous presence of erythromycin. This result rules out any effect of the drug on post-translational mechanisms of error correction.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8852269     DOI: 10.1515/jbcpp.1995.6.3-4.229

Source DB:  PubMed          Journal:  J Basic Clin Physiol Pharmacol        ISSN: 0792-6855


  6 in total

Review 1.  Macrolide resistance conferred by base substitutions in 23S rRNA.

Authors:  B Vester; S Douthwaite
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

Review 2.  The macrolide antibiotic renaissance.

Authors:  George P Dinos
Journal:  Br J Pharmacol       Date:  2017-08-10       Impact factor: 8.739

3.  Identification of essential residues in the Erm(B) rRNA methyltransferase of Clostridium perfringens.

Authors:  Kylie A Farrow; Dena Lyras; Galina Polekhina; Katerina Koutsis; Michael W Parker; Julian I Rood
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

4.  Insights into the mode of action of novel fluoroketolides, potent inhibitors of bacterial protein synthesis.

Authors:  Marios G Krokidis; Viter Márquez; Daniel N Wilson; Dimitrios L Kalpaxis; George P Dinos
Journal:  Antimicrob Agents Chemother       Date:  2013-11-04       Impact factor: 5.191

5.  A Novel Class of Defensive Compounds in Harvestmen: Hydroxy-γ-Lactones from the Phalangiid Egaenus convexus.

Authors:  Günther Raspotnig; Felix Anderl; Olaf Kunert; Miriam Schaider; Adrian Brückner; Mario Schubert; Stefan Dötterl; Roman Fuchs; Hans-Jörg Leis
Journal:  J Nat Prod       Date:  2020-10-16       Impact factor: 4.050

6.  Weakest-Link Dynamics Predict Apparent Antibiotic Interactions in a Model Cross-Feeding Community.

Authors:  Elizabeth M Adamowicz; William R Harcombe
Journal:  Antimicrob Agents Chemother       Date:  2020-10-20       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.